PMC Weekly Review – March 11, 2019

A Macro View – February Monthly Recap
The strong start to 2019 continued for domestic equity markets during February, as progress toward relieving trade hostilities between the US and China and an increasingly dovish Federal Reserve fueled investors’ risk appetite, despite moderating domestic economic data. US equities continued to move higher in a continuation of January’s trend (albeit not as sharply as in January), bouncing back from the severe correction in the fourth quarter of 2018. Growth stocks unsurprisingly outperformed their value counterparts given the risk-on environment, with returns increasing and the growth/value disparity becoming more pronounced further down the market-cap spectrum. Domestic large cap stocks broadly showed positive returns during the month, with the Russell 1000 Growth Index modestly outperforming the Russell 1000 Value Index (3.58% versus 3.19%). The Russell Mid Cap Index was up 4.30% during February, led by Information Technology (8.70%), with growth (5.86%) outperforming value (3.18%) by 2.68%. Small cap US stocks also continued their upward momentum during the month, with the Russell 2000 Index up 5.20%. The charge was led by Information Technology (8.40%) and Health Care (6.10%), as growth (6.46%) continued to outperform value (3.89%). Although the index has not quite made a full recovery to the previous highs reached in late August of 2018, it has risen more than 17% on the year and more than 22% since the lows reached on December 24, 2018, a testament to the strong risk appetite and reversal of trend seen over the first two months of the year.
Outside the US, returns in February were more modest across the board, as international markets trailed their US counterparts during the month, but still posted positive overall returns. Despite the positive performance, economic growth outside the US remains subdued, and political uncertainty continues to weigh on markets in Europe. The UK is fast approaching the March 29 Brexit deadline without a deal, and Spain’s opposition party recently rejected the national budget and called for snap elections. However, these headlines were not enough to derail the MSCI EAFE Index’s continued rebound after the fourth quarter sell-off, and the index gained 2.55% in February. Developments in China also were among the main headlines during the month, as the nation pushed closer to a trade deal with the US. President Trump delayed planned tariff increases that would have gone into effect on March 1, giving a boost to global equity markets. Additionally, China continued to implement stimulus measures to combat its recent economic slowdown, and the effects have begun to surface, with local government bond issuance increasing in February. This spurred China to a solid 3.50% return for the month of February. This was offset in the MSCI EM Index by other emerging markets like Turkey
(-3.50%), which is still reeling in the aftermath of the currency sell-off last year that spurred significant inflation in the country. Overall, emerging markets were flat for the month.
Domestic fixed income markets posted mixed results during February as yields moved higher across the curve, and the Bloomberg Barclays US Aggregate Index fell six basis points during the month. The spread sectors, however, withstood the upward move in rates, as corporate credit spreads tightened across the board, led by US high yield (1.66%) and bank loans (1.59%), both of which outperformed their investment grade counterparts (0.22%). Securitized assets also saw tighter spreads lead to modestly positive returns (CMBS 0.41%, ABS 0.28%), with the exception of Agency MBS, in which spreads widened by three basis points. February was another favorable month for municipal investors, with positive returns across all segments of the market, as strong demand continued to be met by relatively light supply. The longest maturities outperformed both intermediate and short-term municipals last month, and in a return to the theme for much of 2018, lower-quality investment grade credits outperformed higher quality, with the BBB-rated issues leading the way. Municipal bond supply levels will likely increase in coming months given the seasonality of the municipal market, but not enough to match the amount of debt rolling off, leading to an expected negative net supply for all of 2019.
Several factors have been hanging over the non-US fixed income markets for the last few months, but US trade tensions with China have been the biggest headline. In addition, slowing US growth, Brexit, political turmoil in Venezuela, and the failure to reach a nuclear arms deal with North Korea all made significant headlines during the month. The developed fixed income markets were off slightly in February, with the Bloomberg Barclays Global Aggregate ex-US Index down 1.04%. However, this primarily was due to a strengthening US dollar during the month, as the dollar-hedged version of the index was up 22 basis points. The emerging markets were up slightly for the month, with the external currency sovereign index rising 1.00% and the emerging markets corporate index increasing 1.15%. The advance in emerging markets was widespread, with only Venezuela and Argentina turning in negative performance. Emerging markets local currency bonds were down 1.09%, however, as the majority of emerging markets currencies depreciated against the US dollar.
David Hawal, CFA
Vice President, Senior Investment Analyst

Download the full PDF

The information, analysis, and opinions expressed herein are for general and educational purposes only. Nothing contained in this weekly review is intended to constitute legal, tax, accounting, securities, or investment advice, nor an opinion regarding the appropriateness of any investment, nor a solicitation of any type. All investments carry a certain risk, and there is no assurance that an investment will provide positive performance over any period of time. An investor may experience loss of principal. Investment decisions should always be made based on the investor’s specific financial needs and objectives, goals, time horizon, and risk tolerance. The asset classes and/or investment strategies described may not be suitable for all investors and investors should consult with an investment advisor to determine the appropriate investment strategy. Past performance is not indicative of future results.

Information obtained from third party sources are believed to be reliable but not guaranteed. Envestnet|PMC™ makes no representation regarding the accuracy or completeness of information provided herein. All opinions and views constitute our judgments as of the date of writing and are subject to change at any time without notice.

Investments in smaller companies carry greater risk than is customarily associated with larger companies for various reasons such as volatility of earnings and prospects, higher failure rates, and limited markets, product lines or financial resources. Investing overseas involves special risks, including the volatility of currency exchange rates and, in some cases, limited geographic focus, political and economic instability, and relatively illiquid markets. Income (bond) securities are subject to interest rate risk, which is the risk that debt securities in a portfolio will decline in value because of increases in market interest rates. Exchange Traded Funds (ETFs) are subject to risks similar to those of stocks, such as market risk. Investing in ETFs may bear indirect fees and expenses charged by ETFs in addition to its direct fees and expenses, as well as indirectly bearing the principal risks of those ETFs. ETFs may trade at a discount to their net asset value and are subject to the market fluctuations of their underlying investments. Investing in commodities can be volatile and can suffer from periods of prolonged decline in value and may not be suitable for all investors. Index Performance is presented for illustrative purposes only and does not represent the performance of any specific investment product or portfolio. An investment cannot be made directly into an index.

Alternative Investments may have complex terms and features that are not easily understood and are not suitable for all investors. You should conduct your own due diligence to ensure you understand the features of the product before investing. Alternative investment strategies may employ a variety of hedging techniques and non-traditional instruments such as inverse and leveraged products. Certain hedging techniques include matched combinations that neutralize or offset individual risks such as merger arbitrage, long/short equity, convertible bond arbitrage and fixed-income arbitrage. Leveraged products are those that employ financial derivatives and debt to try to achieve a multiple (for example two or three times) of the return or inverse return of a stated index or benchmark over the course of a single day. Inverse products utilize short selling, derivatives trading, and other leveraged investment techniques, such as futures trading to achieve their objectives, mainly to track the inverse of their benchmarks. As with all investments, there is no assurance that any investment strategies will achieve their objectives or protect against losses.

Neither Envestnet, Envestnet|PMC™ nor its representatives render tax, accounting or legal advice. Any tax statements contained herein are not intended or written to be used, and cannot be used, for the purpose of avoiding U.S. federal, state, or local tax penalties. Taxpayers should always seek advice based on their own particular circumstances from an independent tax advisor.

© 2019 Envestnet. All rights reserved.